Bio Essence Corporation

AI-generated fair value estimate for this company.

Method: Normalized-earnings capitalization: $0.0243 TTM EPS ($1.31M net income / 53.81M shares outstanding); applied a conservative 8x P/E multiple reflecting the elevated risk, thin trading liquidity, and limited operating history typical of a micro-cap OTC health-supplement company.

Reasoning: Bio Essence is a small, recently-profitable OTC manufacturer and distributor of health supplements with extreme share-price volatility (52-week range of $0.05-$0.52) and limited public financial history, making a multi-year FCF DCF unreliable; a conservative earnings-multiple approach anchored well below typical market multiples better reflects the going-concern and liquidity risk of this name.